Business Wire

CA-NETAPP

7.2.2023 14:02:45 CET | Business Wire | Press release

Share
NetApp Announces New Line of Low-Cost, Capacity Flash Storage for the Modern Data Center

NetApp® (NASDAQ: NTAP), a global, cloud-led, data-centric software company, today announced the upcoming availability of the NetApp AFF C-Series, a new family of capacity flash storage options that deliver lower cost all-flash storage, and NetApp AFF A150, a new entry-level storage system in the AFF A-Series family of all-flash systems.

The new NetApp AFF C-Series delivers flash performance, while remaining cost-effective and efficient for a lower total cost of ownership (TCO) and a smaller storage footprint. This family of capacity flash arrays are also offered with one of the industry’s most comprehensive software suites, ONTAP One, an all-in-one license that includes all available NetApp software. Customers can modernize their data center with the flexibility to choose the right storage (performance flash, capacity flash, or hybrid) for their VMware, database, and file workload requirements, all running on NetApp ONTAP and managed centrally by NetApp BlueXP for a seamless hybrid cloud experience.

NetApp also announced today, NetApp Advance, a new portfolio of storage programs and guarantees to deliver best-in-class customer ownership experience and cost-effectively future proof on-premises environments.* This gives customers the flexibility and choice to safeguard their storage investment – whether the C-Series, AFF A150 or other newly acquired AFF or FAS systems – with the ability to right-size on-premises environments and transition to storage as a service or cloud storage as their business requires. And with NetApp’s 4:1 Storage Efficiency Guarantee,* NetApp ensures that workload efficiency goals are met, or NetApp will rectify this at no cost to the customer.

“NetApp has been a flash storage leader for years, and today’s announcements of the AFF C-Series and A150 builds on that legacy of innovation to bring our customers and partners some of the most affordable and sustainable all flash storage in the market today,” said Sandeep Singh, Senior Vice President, Enterprise Storage at NetApp. “As companies are looking at their bottom line in this economic environment, we want to meet their needs by providing capacity flash at a lower cost to entry in order to better enable their transition from hybrid storage to all-flash while staying in budget.”

The NetApp AFF C-Series, which is comprised of the AFF C250, AFF C400 and AFF C800, offers:

  • Guaranteed storage efficiency to improve an organization’s storage footprint and energy costs to reduce TCO while simplifying operations.*
  • Seamless scalability on-premises to allow organizations to scale capacity and performance as their data grows.
  • Best-in-class data security with ransomware protection to keep important data secure, available and protected.

The new NetApp AFF A150 is ideal for Mid-size businesses, and Remote Office/Branch Office (ROBO) and distributed deployments to better meet the needs of customers who require entry-level, enterprise-class storage, while providing:

  • Better performance
  • More scalability and expansion options
  • High availability with support for MetroCluster IP

These additions to NetApp’s product line-up are ideal for entry-level to high-end workloads (including virtual machines, database, and backup consolidation), are feature-rich with ONTAP data management, and are offered at an attractive price point for customers – creating strong growth opportunities for NetApp partners to reach new markets while qualifying for NetApp Partner Sphere incentives.

“NetApp continues to assert itself as one of the market’s preeminent innovators for hybrid cloud storage,” said Juan Orlandini, Chief Architect and Distinguished Engineer at Insight Enterprises. “As a leading solutions integrator and longtime NetApp partner, we know our joint customers are looking for the industry’s most innovative solutions and services to enable speed, scale and resilience for their business. With these new capacity flash and entry level offerings, we’re opening the door to acquire new customers at scale.”

NetApp Advance is available today. The NetApp AFF C-Series family and NetApp AFF A150 will be available starting in March 2023, and NetApp and Cisco plan to offer these storage options within the industry-leading integrated infrastructure offering, FlexPod, in Q4 FY’23.

*Terms and conditions will apply.

Additional Resources

About NetApp

NetApp is a global, cloud-led, data-centric software company that empowers organizations to lead with data in the age of accelerated digital transformation. The company provides systems, software and cloud services that enable them to run their applications optimally from data center to cloud, whether they are developing in the cloud, moving to the cloud, or creating their own cloudlike experiences on premises. With solutions that perform across diverse environments, NetApp helps organizations build their own data fabric and securely deliver the right data, services, and applications to the right people—anytime, anywhere. Learn more at www.netapp.com or follow us on Twitter, LinkedIn, Facebook, and Instagram.

NETAPP, the NETAPP logo, and the marks listed at www.netapp.com/TM are trademarks of NetApp, Inc. Other company and product names may be trademarks of their respective owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230207005482/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye